Muutke küpsiste eelistusi

E-raamat: Using Functional Genomics and Artificial Intelligence to Reverse Engineer Human Cancer Cells

  • Formaat: 161 pages
  • Ilmumisaeg: 19-Jan-2023
  • Kirjastus: Cambridge Scholars Publishing
  • ISBN-13: 9781527592315
  • Formaat - PDF+DRM
  • Hind: 113,09 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Formaat: 161 pages
  • Ilmumisaeg: 19-Jan-2023
  • Kirjastus: Cambridge Scholars Publishing
  • ISBN-13: 9781527592315

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Tremendous progress has been made in the war on cancer, leading to improvements in cancer prevention, detection, and treatment. Together, these advances have resulted in decreasing incidences and a steadily declining death rate from cancer. However, for patients who develop stage IV cancer, cancer that has spread to distant organs, their prognosis remains grim. Conventional chemotherapy is limited in its ability to successfully eradicate metastatic disease. Therefore, new modalities and approaches are desperately needed if we are to make progress toward conquering this last mountaintop of cancer research. This book lays out the rationale for a novel therapeutic strategy using new targeted drugs to develop effective ways to treat patients with metastatic cancer. This strategy uses artificial intelligence methods to leverage the vast amounts of genomic data that have become available in recent years to develop precise and personalized methods of treating patients with metastatic cancer. This strategy, together with modern approaches to immunotherapy, offers hope to the eventual routine cure of metastatic cancer.
Stephen P. Ethier, PhD, is Professor of Pathology and Laboratory Medicine at the Medical University of South Carolina, having previously served as Associate Director for Basic Research and Deputy Director of the Barbara Ann Karmanos Cancer Institute, and Professor of Oncology at Wayne State University, USA. Dr Ethier has spent his entire career studying the biology of breast cancer. In recent years, his work has focused on the genomic alterations that drive breast cancer development and how those genomic changes lead to the expression of malignant phenotypes and drug sensitivities in breast cancer cells. His publications include over 140 peer reviewed scientific papers, and The Lewis Exchange, his first work of fiction.